DeanFelsherMD

Professor, Medicine - Oncology, Stanford University Medical Center

Dr. Felsher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1994 - 1998
University of Pennsylvania Health SystemResidency, Internal Medicine, 1992 - 1994
David Geffen School of Medicine at UCLAClass of 1992

PubMed

1 citations
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease.
Lea Lemaitre, Nia Adeniji, Akanksha Suresh, Reshma Reguram, Josephine Zhang
Nature Cancer. 2024-10-01
A big step for MYC-targeted therapies.
Danielle F Atibalentja, Anja Deutzmann, Dean W Felsher
Trends in Cancer. 2024-05-01
2 citations
Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma.
Anja Deutzmann, Delaney K Sullivan, Renumathy Dhanasekaran, Wei Li, Xinyu Chen
Nature Communications. 2024-02-01

Abstracts/Posters

The Glutathione Redox System Is Essential to Prevent Ferroptosis Caused by Impaired Lipid Metabolism in Clear Cell Renal Cell Carcinoma
Dean Felsher, MD, Nature, Orlando, FL, 12/9/2019

Liver Cancer Stem Cells Shown to Use Immune System as Shield to Spark Disease RecurrenceOctober 9th, 2024
How Cancer Gene Tricks Immune Cells to Stand DownMarch 27th, 2023
Phuoc T. Tran, MD, PhD: Focus on Translational MedicineFebruary 14th, 2022
Join now to see all